Multi-hospital analysis of antimicrobial usage and resistance trends

Amsden, 1995, Tables of antimicrobial agent pharmacology, 506 Archibald, 1997, Antimicrobial resistance in isolates from inpatients and outpatients in the United States. Increasing importance of the ICU, Clinical Infectious Diseases, 24, 211, 10.1093/clinids/24.2.211 CDC. (1995). Recommendation for preventing the spread of vancomycin resistance. Recommendation of the Hospital Infection Control Practices Advisory Committee (HICPAC). Morbidity and Mortality Weekly Report, 44, 1–13. Dahms, 1998, Third generation cephalosporins and vancomycin as risk factors for postoperative VRE infection, Archives of Surgery, 132, 1343, 10.1001/archsurg.133.12.1343 Edgeworth, 1999, A 25-year study of nosocomial bacteremia in an adult intensive care unit, Critical Care Medicine, 27, 1421, 10.1097/00003246-199908000-00002 Edlund, 1997, Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy, Clinical Infectious Diseases, 25, 729, 10.1086/513755 Edmond, 1995, Vancomycin-Resistant Enterococcus faecium bacteremia, Clinical Infectious Diseases, 20, 1126, 10.1093/clinids/20.5.1126 Fridkin, 1999, Determinants of vancomycin use in adult intensive care units in 41 United States Hospitals, Clinical Infectious Diseases, 28, 1119, 10.1086/514752 Gerding, 1997, Is there a relationship between VRE infection and Clostridium difficile infection, Clinical Infectious Diseases, 25, S206, 10.1086/516247 Gordts, 1995, Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients, Journal of Clinical Microbiology, 33, 2842, 10.1128/JCM.33.11.2842-2846.1995 Gruson, 2000, Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria, American Journal of Respiratory & Critical Care, 162, 837, 10.1164/ajrccm.162.3.9905050 Jacobson, 1995, The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group 1 β-lactamase-producing organisms, Clinical Infectious Diseases, 21, 1107, 10.1093/clinids/21.5.1107 Jones, 1994, Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the US, Study on the threat of emerging reistance: real or perceived? Diagnostic Microbiology and Infectious Diseases, 19, 203, 10.1016/0732-8893(94)90033-7 Kim, 1999, The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period, Journal of Infectious Diseases, 179, 163, 10.1086/314564 Kolar, 2001, Antibiotic selective pressure and development of bacterial resistance, International Journal of Antimicrobial Agents, 17, 357, 10.1016/S0924-8579(01)00317-X Marshall, 1998, Staphylococcus aureus, and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mec A) characterization of oxacillin resistance in the SCOPE program. Diagnostic Microbiology and Infectious Diseases, 30, 205 McGowan, 1998, Antimicrobial resistance in the ICU, impact of new patterns, International Journal of Clinical Practice Suppl, 95, 14 Monnet, 1998, Antimicrobial use and resistance in eight US hospitals, Infection Control and Hospital Epidemiology, 19, 388, 10.1086/647837 Morris, 1995, Enterococci resistant to multiple antimicrobial agents, including vancomycin, Annals of Internal Medicine, 123, 250, 10.7326/0003-4819-123-4-199508150-00002 Pegues, 1997, Emergence and dissemination of a highly vancomycin-resistant van A strain of Enterococcus faecium at a large teaching hospital, Journal of Clinical Microbiology, 35, 1565, 10.1128/JCM.35.6.1565-1570.1997 Peña, C., Pujo, M., Ardanuy, C., Ricart, A., Pallares, R., Linares, J., Ariza, J., & Gudial (1998). Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum Beta-lactamases. Antimicrobial Agents and Chemotherapy, 42, 53–57. Quale, 1996, Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci, Clinical Infectious Diseases, 23, 1020, 10.1093/clinids/23.5.1020 Rahal, 1998, Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella, Journal of the American Medical Association, 280, 1233, 10.1001/jama.280.14.1233 Rice, 1990, Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility, Antimicrobial Agents and Chemotherapy, 34, 2193, 10.1128/AAC.34.11.2193 Schwartz, D. N., Itokazu, G. S., Glowacki, R. C., Rydman, R. J., Wisniewski, M. F., & Weinstein, R. A. (2000). Antibiotic consumption data from pharmacy and nursing records: how good are they? Abstract #439: 38th Annual Infectious Disease Society of America. Slaughter, 1996, A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit, Annals of Internal Medicine, 125, 448, 10.7326/0003-4819-125-6-199609150-00004 Tornieporth, 1996, Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients, Clinical Infectious Diseases, 23, 767, 10.1093/clinids/23.4.767 Weinstein, 1998, Nosocomial infection update, Emerging Infectious Diseases, 4, 416, 10.3201/eid0403.980320 Weischer, 1994, Resistance characteristics of blood culture isolates of Enterobacter cloacae with special reference to β-lactamases and relation to preceding antimicrobial therapy, APMIS, 102, 356, 10.1111/j.1699-0463.1994.tb04884.x White, 2000, Assessment of the relationship between antimicrobial usage and susceptibility, Clinical Infectious Diseases, 31, 16, 10.1086/313916